BGIM
AGN

Boussard & Gavaudan Investment Management’s Allergan plc AGN Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,148,847
Closed -$204M – 53
2020
Q1 		$204M Sell
1,148,847
-174,555
-13% -$32.9M 44.31% 1
2019
Q4 		$252M Buy
1,323,402
+21,499
+2% +$3.88M 56.13% 1
2019
Q3 		$219M Buy
+1,301,903
New +$212M 29.4% 2
2016
Q2 		– Sell
-835
Closed -$229K – 24
2016
Q1 		$229K Sell
835
-355
-30% -$102K 0.12% 17
2015
Q4 		$375K Hold
1,190
– – 0.47% 9
2015
Q3 		$317K Hold
1,190
– – 0.51% 7
2015
Q2 		$357K Hold
1,190
– – 0.39% 10
2015
Q1 		$361K Hold
1,190
– – 0.23% 9
2014
Q4 		$309K Hold
1,190
– – 0.2% 8
2014
Q3 		$288K Buy
+1,190
New +$266K 0.17% 14

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Boussard & Gavaudan Investment Management's AGN Position: Q2 2020 in Review

Boussard & Gavaudan Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,148,847 shares — an estimated $204M sold.

Boussard & Gavaudan Investment Management first reported a position in AGN in Q3 2014 and held it in 10 quarters. The position peaked at $252M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Boussard & Gavaudan Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 1,148,847 Allergan plc shares in Q2 2020, an estimated $204M.
  • Boussard & Gavaudan Investment Management first reported a position in Allergan plc in Q3 2014 and held it in 10 quarters.
  • Boussard & Gavaudan Investment Management's Allergan plc position peaked at $252M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q2 2020, filed 9 Jul 2020.